Q2 2025 · 13F-HR
TPG GP A, LLCholdings as filed
Filed 2025-08-14 · accession 0001999371-25-011364
$1.88B
Reported value
9
Positions
2025-06-30
Period end
The Brief · TPG GP A, LLC · Q2 2025
AI · grounded in 13F
TPG GP A, LLC established a new position in LifeStance Health Group Inc LFST valued at $830.9M. The fund also initiated a stake in Life Time Group Holdings Inc LTH for $649.2M. Additional new positions include Sionna Therapeutics Inc SION at $117M and Amneal Pharmaceuticals Inc AMRX at $99.7M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 53228F101 | LFST | LifeStance Health Group Inc | $830.9M | 44.3% | 160,711,618 | Common | SOLE |
| 53190C102 | LTH | Life Time Group Holdings Inc | $649.2M | 34.6% | 21,404,488 | Common | SOLE |
| 829401108 | SION | Sionna Therapeutics Inc | $117.0M | 6.24% | 6,744,962 | Common | SOLE |
| 03168L105 | AMRX | Amneal Pharmaceuticals Inc | $99.7M | 5.32% | 12,328,767 | Common | SOLE |
| 15678C102 | CBLL | CeriBell Inc. | $74.3M | 3.96% | 3,967,422 | Common | SOLE |
| 87266M107 | TRTX | TPG RE Fin Tr Inc | $54.7M | 2.92% | 7,086,779 | Common | SOLE |
| 055477103 | BCAX | Bicara Therapeutics Inc. | $28.0M | 1.49% | 3,010,425 | Common | SOLE |
| 019770106 | ALLO | Allogene Therapeutics Inc | $21.1M | 1.13% | 18,716,306 | Common | SOLE |
| 75120L100 | RLYB | Rallybio Corp | $1.0M | 0.05% | 3,028,414 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.